Engineered liver tissues, arrays thereof, and methods of making the same

Patent metadata

Field	Value
Publication number	US-9442105-B2
Application number	US-201313841430-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	Mar 15, 2013
Publication date	Sep 13, 2016
Grant date	Sep 13, 2016

Abstract

Engineered, living, three-dimensional liver tissue constructs comprising: one or more layers, wherein each layer contains one or more liver cell types, the one or more layers cohered to form a living, three-dimensional liver tissue construct. In some embodiments, the constructs are characterized by having at least one of: at least one layer comprising a plurality of cell types, the cell types spatially arranged relative to each other to create a planar geometry; and a plurality of layers, at least one layer compositionally or architecturally distinct from at least one other layer to create a laminar geometry. Also disclosed are arrays and methods of making the same. Also disclosed are engineered, living, three-dimensional liver tissue constructs for use in the augmentation or restoration of one or more liver functions, by in vivo delivery of tissue or utilization of tissue in an extracorporeal device.

First claim

What is claimed is:

1. A method of fabricating a living, three-dimensional liver tissue construct comprising:
a. preparing one or more bio-inks comprising non-parenchymal cells;
b. preparing one or more bio-inks comprising parenchymal cells, the parenchymal cells comprising hepatocytes or hepatocyte-like cells;
c. depositing the bio-inks onto a support to form at least one compartment, the compartment comprising an interior comprising parenchymal cells confined by a border comprising non-parenchymal cells, the border completely surrounding the interior and in continuous contact with the interior; and
d. incubating the deposited bio-inks for a duration of about 1 hour to about 30 days to allow the cells to cohere to form a living, three-dimensional liver tissue construct at least 3 cells thick in its smallest dimension or at least 50 μm thick in its smallest dimension.

2. The method of claim 1 , wherein the non-parenchymal cells comprise one or more of: vascular cells, endothelial cells, fibroblasts, mesenchymal cells, immune cells, cancer cells, Kupffer cells, stellate cells, biliary epithelial cells, biliary epithelial-like cells, sinusoidal endothelial cells, liver-derived stem/progenitor cells, and non-liver-derived stem/progenitor cells.

3. The method of claim 1 , wherein the parenchymal cells are derived from one or more of the following sources: adult mammalian liver tissue; fetal mammalian liver tissue; embryonic stem cells (ESC); induced pluripotent stem cells (IPSC); adult stem/progenitor cells derived from the liver; and adult stem/progenitor cells derived from a tissue other than liver.

4. The method of claim 1 , wherein at least one component of the construct is bioprinted.

5. The method of claim 4 , further comprising an extrusion compound, the extrusion compound improving the suitability of the cells for bioprinting.

6. The method of claim 1 , wherein the construct is substantially free of any pre-formed scaffold at the time of use in an assay, implantation into a subject, or for use in extracorporeal support of a subject.

7. The method of claim 1 , wherein the construct is non-innervated.

8. The method of claim 1 , wherein hepatocytes or hepatocyte-like cells comprise ESC-derived hepatocyte-like cells or IPSC-derived hepatocyte-like cells.

9. The method of claim 1 , wherein the depositing of the bio-inks is repeated one or more times to create a plurality of layers.

10. The method of claim 1 , wherein the parenchymal cells or the non-parenchymal cells comprise stem/progenitor cells.

11. The method of claim 10 , further comprising exposing the stem/progenitor cells to one or more differentiation signals.

Assignees

• Organovo Inc

Inventors

• Shepherd Benjamin R
• Robbins Justin B
• Gorgen Vivian A
• Presnell Sharon C

Classifications

• A61P1/16

  for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics · CPC title

• G01N33/5088

  of vertebrates · CPC title

• C12N2533/30

  Synthetic polymers · CPC title

• G01N33/5008 Primary

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title

• C12N2535/10

  Patterned coating · CPC title